Inclusion completed

A phase II single arm clinical trial of nivolumab (BMS936558) in subjects with metastatic or unresectable urothelial cancer who have progressed or recurred following treatment with a platinum agent

Cancer type: Bladder cancer

Phase: II

Principal Investigator: Peltola Katriina

Country: FI

Keywords: Finland, Helsinki

Status: Inclusion completed

Link to